Plasmapheresis in neuroleptic malignant syndrome

L. Gaitini, M. Fradis, S. Vaida, S. Krimerman, A. Beny

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


Neuroleptic malignant syndrome is a severe and potentially fatal reaction to neuroleptic drugs. Treatment requires withdrawal of the neuroleptic agent, metabolic and cardiovascular support, physical cooling and treatment with dantrolene sodium and bromcriptine mesylate. We report a therapeutic success of plasmapheresis in a case of neuroleptic malignant syndrome in which conventional therapy had failed. We postulate that plasmapheresis may prove to be a useful tool in treating this frequently fatal disease.

Original languageEnglish (US)
Pages (from-to)165-168
Number of pages4
Issue number2
StatePublished - 1997

All Science Journal Classification (ASJC) codes

  • Anesthesiology and Pain Medicine


Dive into the research topics of 'Plasmapheresis in neuroleptic malignant syndrome'. Together they form a unique fingerprint.

Cite this